Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Hepar

Glycomic Therapeutics Global Market Report 2023

Including: 1) By Class: Isolated; Synthetic2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And BCovering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc


Glycomic Therapeutics Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glycomic therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for glycomic therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glycomic therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Class: Isolated; Synthetic

2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids; Other Structures

3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons; Other Mode Of Action

4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B; Other Indications

Companies Mentioned: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Glycomic Therapeutics Market Characteristics
3. Glycomic Therapeutics Market Trends And Strategies
4. Glycomic Therapeutics Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Glycomic Therapeutics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Glycomic Therapeutics Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Glycomic Therapeutics Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Glycomic Therapeutics Market Segmentation
6.1. Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Isolated
Synthetic
6.2. Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Glycoproteins
Targeting Sialic Acid
Proteoglycans
Targeting Glycosaminoglycans
Glycosylphosphatidylinositol (Gpi)-Anchored Proteins And Heparin Based Glycans
Targeting Glycosphingolipids
Other Structures
6.3. Global Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Inhibits Neuraminidase
Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate
Erythropoietin And Enzyme Replacement Therapy (Ert)
Tissue Plasminogen Activator
Inhibits Glucosylceramide Synthase
Interleukin 1, 2 And 3
Beta And Gamma Interferons
Other Mode Of Action
6.4. Global Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Thrombosis And Chemoprophylaxis
Anaemia
Anti-Adhesive And Anti-Inflammatory
Cataracts
Gaucher’S Disease
Mps-1 And Iv
Cancer
Alzheimer’S Disease
Influenza Type A And B
Other Indications
7. Glycomic Therapeutics Market Regional And Country Analysis
7.1. Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Glycomic Therapeutics Market
8.1. Asia-Pacific Glycomic Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Glycomic Therapeutics Market
9.1. China Glycomic Therapeutics Market Overview
9.2. China Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Glycomic Therapeutics Market
10.1. India Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Glycomic Therapeutics Market
11.1. Japan Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Glycomic Therapeutics Market
12.1. Australia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Glycomic Therapeutics Market
13.1. Indonesia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Glycomic Therapeutics Market
14.1. South Korea Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Glycomic Therapeutics Market
15.1. Western Europe Glycomic Therapeutics Market Overview
15.2. Western Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Glycomic Therapeutics Market
16.1. UK Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Glycomic Therapeutics Market
17.1. Germany Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Glycomic Therapeutics Market
18.1. France Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Glycomic Therapeutics Market
19.1. Italy Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Glycomic Therapeutics Market
20.1. Spain Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Glycomic Therapeutics Market
21.1. Eastern Europe Glycomic Therapeutics Market Overview
21.2. Eastern Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Glycomic Therapeutics Market
22.1. Russia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Glycomic Therapeutics Market
23.1. North America Glycomic Therapeutics Market Overview
23.2. North America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Glycomic Therapeutics Market
24.1. USA Glycomic Therapeutics Market Overview
24.2. USA Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Glycomic Therapeutics Market
25.1. Canada Glycomic Therapeutics Market Overview
25.2. Canada Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Glycomic Therapeutics Market
26.1. South America Glycomic Therapeutics Market Overview
26.2. South America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Glycomic Therapeutics Market
27.1. Brazil Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Glycomic Therapeutics Market
28.1. Middle East Glycomic Therapeutics Market Overview
28.2. Middle East Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Glycomic Therapeutics Market
29.1. Africa Glycomic Therapeutics Market Overview
29.2. Africa Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Glycomic Therapeutics Market Competitive Landscape And Company Profiles
30.1. Glycomic Therapeutics Market Competitive Landscape
30.2. Glycomic Therapeutics Market Company Profiles
30.2.1. F Hoffmann-La Roche Ltd.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Bayer AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Sanofi SA
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Thermo Fisher Scientific Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. GlaxoSmithKline plc
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Glycomic Therapeutics Market Other Major And Innovative Companies
31.1. Merck KGaA
31.2. ICON plc
31.3. Agilent Technologies Inc.
31.4. AMS Bio
31.5. Shimadzu Corporation
31.6. Waters Corporation
31.7. Bruker Corporation
31.8. BioMarin Pharmaceutical Inc.
31.9. Bio Techne Corp.
31.10. Promega Corporation
31.11. Halozyme Therapeutics Inc.
31.12. Takara Bio Inc.
31.13. Vector Laboratories
31.14. New England Biolabs Inc.
31.15. Protalix Biotherapeutics Inc.
32. Global Glycomic Therapeutics Market Competitive Benchmarking
33. Global Glycomic Therapeutics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Glycomic Therapeutics Market
35. Glycomic Therapeutics Market Future Outlook and Potential Analysis
35.1 Glycomic Therapeutics Market In 2027 - Countries Offering Most New Opportunities
35.2 Glycomic Therapeutics Market In 2027 - Segments Offering Most New Opportunities
35.3 Glycomic Therapeutics Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings